The company said the discontinuation was due to several reasons,” Reuters news service reported, “including limited interest ...

A vocal opponent of his predecessor Peter Marks, Vinay Prasad will now lead the office tasked with reviewing some genetic ...

The mood at the annual meeting of the American Society of Cell and Gene Therapy isn’t amazing. The biotech market has been ...

Gene therapy is at the cutting edge of medicine, with exciting new products being developed and used to treat a wide variety ...

Gene therapies offer incredible promise for treating diseases with a genetic component. Several gene therapies are already ...

In June, the Centers for Medicare & Medicaid Services (CMS) will name the participating states for the agency’s new Cell and ...

Cell and gene therapies (CGTs) are revolutionizing the landscape of personalized medicine, offering treatments that were once ...

Healthcare providers are exploring ways to reduce patient travel through a growing trend of expanding sites of administration ...

Explore ClearPoint Neuro's Q1 2025 performance, with 11% revenue growth, strategic investments, and strong biopharma partnerships.

As we continue to see sequencing technologies advance and provide a deeper understanding of gene therapy targets along with ...

The U.S. Food and Drug Administration approved Abeona Therapeutics' gene therapy for a rare skin disorder on Tuesday.

GEN2 is well tolerated with minimal toxicity and signs of pharmacodynamic activity in an ongoing Phase 1 dose escalation and ...